All Companies

LLYCongressional Stock Trades

Eli Lilly & Co.

Pharmaceutical Preparations

Congressional stock trades in Eli Lilly & Co. (LLY) from House and Senate STOCK Act filings. See which members of Congress bought or sold, disclosed amounts, and filing dates.

Total Trades

53

Politicians Trading

22

Last Traded

Jul 10, 2026

Trading History

PoliticianNotifiedTradedTypeAmountChange
Michael A. RulliRAug 7, 2026Jul 1, 2026Sell$1,001 - $15,000+18.40%
Michael A. RulliRAug 7, 2026Jan 2, 2026Buy$1,001 - $15,000+30.60%
Michael A. RulliRAug 7, 2026Dec 2, 2025Sell$1,001 - $15,000+34.88%
Alan ArmstrongRJul 21, 2026Mar 27, 2026Sell$1,001 - $15,000+60.66%
Dan NewhouseRJul 17, 2026Jul 10, 2026Sell$1,001 - $15,000+18.71%
Gilbert Ray Cisneros, Jr.DJul 2, 2026Jun 10, 2026Buy$50,001 - $100,000+24.17%
Byron DonaldsRMay 13, 2026Apr 2, 2026Buy$1,001 - $15,000+50.81%
Byron DonaldsRMay 13, 2026Apr 2, 2026Buy$1,001 - $15,000+50.81%
David TaylorRMar 6, 2026Feb 26, 2026Buy$1,001 - $15,000+38.06%
David TaylorRFeb 20, 2026Feb 9, 2026Sell$1,001 - $15,000+35.07%
David TaylorRFeb 2, 2026Jan 16, 2026Sell$1,001 - $15,000+35.88%
Angus S. King Jr.IJan 26, 2026Dec 29, 2025Buy$1,001 - $15,000+30.80%
Markwayne MullinRJan 16, 2026Dec 29, 2025Buy$15,001 - $50,000+30.80%
Julie JohnsonDJan 15, 2026Dec 18, 2025Sell$1,001 - $15,000+33.51%
David TaylorRDec 19, 2025Dec 10, 2025Sell$1,001 - $15,000+42.00%
Gilbert Ray Cisneros, Jr.DDec 15, 2025Nov 18, 2025Buy$1,001 - $15,000+36.98%
Julie JohnsonDDec 11, 2025Nov 13, 2025Sell$1,001 - $15,000+37.94%
John BoozmanRDec 8, 2025Nov 21, 2025Sell$1,001 - $15,000+33.15%
Shelley Moore CapitoRNov 4, 2025Oct 24, 2025Buy$1,001 - $15,000+70.94%
Val T. HoyleDOct 10, 2025Sep 23, 2025Sell$1,001 - $15,000+88.89%
John BoozmanRSep 12, 2025Aug 22, 2025Buy$1,001 - $15,000+98.26%
John BoozmanRSep 12, 2025Aug 11, 2025Buy$1,001 - $15,000+122.13%
Val T. HoyleDSep 12, 2025May 6, 2025Sell$1,001 - $15,000+82.04%
Julie JohnsonDSep 11, 2025Aug 14, 2025Sell$1,001 - $15,000+106.16%
David TaylorRSep 2, 2025Aug 14, 2025Buy$15,001 - $50,000+106.16%
David TaylorRSep 2, 2025Aug 14, 2025Buy$1,001 - $15,000+106.16%
Jonathan L. JacksonDAug 25, 2025May 21, 2025Sell$1,001 - $15,000+94.63%
Jonathan L. JacksonDAug 25, 2025Apr 23, 2025Buy$1,001 - $15,000+70.12%
Lisa C. McClainRAug 13, 2025Jul 16, 2025Sell$1,001 - $15,000+78.65%
Lisa C. McClainRAug 13, 2025Jul 10, 2025Buy$1,001 - $15,000+78.46%
Lisa C. McClainRAug 13, 2025Jun 9, 2025Sell$1,001 - $15,000+82.37%
Jonathan L. JacksonDJul 14, 2025Jun 3, 2025Sell$15,001 - $50,000+87.94%
Jefferson ShreveRJun 22, 2025May 12, 2025Sell$100,001 - $250,000+86.75%
Josh GottheimerDJun 11, 2025May 13, 2025Sell$1,001 - $15,000+89.13%
Josh GottheimerDJun 11, 2025May 1, 2025Buy$1,001 - $15,000+77.68%
Gilbert Ray Cisneros, Jr.DJun 6, 2025May 30, 2025Sell$1,001 - $15,000+91.28%
Marjorie Taylor GreeneRMay 19, 2025May 14, 2025Buy$1,001 - $15,000+97.19%
Dan NewhouseRMay 16, 2025Apr 11, 2025Sell$1,001 - $15,000+92.65%
Tommy TubervilleRMay 15, 2025Apr 15, 2025Sell$15,001 - $50,000+86.35%
Josh GottheimerDMay 14, 2025Apr 9, 2025Sell$1,001 - $15,000+87.21%
Julie JohnsonDMay 14, 2025Apr 7, 2025Sell$1,001 - $15,000+94.96%
Jonathan L. JacksonDMay 13, 2025Apr 21, 2025Buy$15,001 - $50,000+72.49%
Bruce WestermanRMay 12, 2025Apr 21, 2025Sell$1,001 - $15,000+72.49%
Marjorie Taylor GreeneRMay 6, 2025May 5, 2025Buy$1,001 - $15,000+71.77%
Robert BresnahanRApr 28, 2025Apr 8, 2025Sell$1,001 - $15,000+94.29%
Bruce WestermanRApr 16, 2025Mar 3, 2025Buy$1,001 - $15,000+51.77%
Josh GottheimerDApr 10, 2025Mar 10, 2025Sell$1,001 - $15,000+70.05%
Ashley MoodyRMar 22, 2025Mar 6, 2025Buy$100,001 - $250,000+54.58%
Josh GottheimerDMar 6, 2025Feb 19, 2025Sell$1,001 - $15,000+62.73%
Ron WydenDFeb 21, 2025Feb 10, 2025Sell$50,001 - $100,000+62.39%

Page 1 of 2

Price History

About Eli Lilly & Co.

Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.

FAQ

22 members of Congress have disclosed 53 trades in Eli Lilly & Co. (LLY). Most active: David Taylor (6), Josh Gottheimer (6), Jonathan L. Jackson (4).

Across all disclosures, members of Congress reported 23 purchases and 30 sales of Eli Lilly & Co. (LLY). The most recent trade was on Jul 10, 2026.

Gilbert Ray Cisneros, Jr. disclosed buying Eli Lilly & Co. (LLY) on Jun 10, 2026, valued at $50,001 - $100,000.

Dan Newhouse disclosed selling Eli Lilly & Co. (LLY) on Jul 10, 2026, valued at $1,001 - $15,000.

From House and Senate periodic transaction reports filed under the STOCK Act. Members of Congress must disclose trades within 45 days, and amounts are reported as ranges, not exact values.